REGENEREX PHARMA, INC. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
REGENEREX PHARMA, INC. reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$76.16 thousand for the 12-month period ending 2023-03-31, per its 10-K filed 2023-06-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2023-06-09
- REGENEREX PHARMA, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2023-03-31 was -$3.02K.
- REGENEREX PHARMA, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2022-12-31 was -$28.63K.
- REGENEREX PHARMA, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2022-09-30 was -$9.44K.
- REGENEREX PHARMA, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2022-06-30 was -$35.07K.
- REGENEREX PHARMA, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2023 was -$76.16K.
- REGENEREX PHARMA, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2022 was -$64.41K.
- REGENEREX PHARMA, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2021 was -$45.40K.
- REGENEREX PHARMA, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was -$71.64K.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 53 month |
|---|---|---|---|---|---|
| 2023-03-31 | -$3.02K derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-09 | -$31.65K derived: sum of 2 quarters · filed 2023-06-09 | -$41.10K derived: sum of 3 quarters · filed 2023-06-09 | -$76.16K 10-K · filed 2023-06-09 | |
| 2022-12-31 | -$28.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-01-24 | -$38.07K derived: sum of 2 quarters · filed 2023-01-24 | -$73.14K 10-Q · filed 2023-01-24 | -$83.26K derived: sum of 4 quarters · filed 2023-06-09 | |
| 2022-09-30 | -$9.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-07 | -$44.51K 10-Q · filed 2022-11-07 | -$54.63K derived: sum of 3 quarters · filed 2023-06-09 | -$71.20K derived: sum of 4 quarters · filed 2023-06-09 | |
| 2022-06-30 | -$35.07K 10-Q · filed 2022-08-09 | -$45.19K derived: sum of 2 quarters · filed 2023-06-09 | -$61.76K derived: sum of 3 quarters · filed 2023-06-09 | -$82.26K derived: sum of 4 quarters · filed 2023-06-09 | |
| 2022-03-31 | -$10.12K derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-09 | -$26.69K derived: sum of 2 quarters · filed 2023-06-09 | -$47.19K derived: sum of 3 quarters · filed 2023-06-09 | -$64.41K 10-K · filed 2023-06-09 | |
| 2021-12-31 | -$16.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-01-24 | -$37.07K derived: sum of 2 quarters · filed 2023-01-24 | -$54.29K 10-Q · filed 2023-01-24 | ||
| 2021-09-30 | -$20.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-07 | -$37.72K 10-Q · filed 2022-11-07 | |||
| 2021-06-30 | -$17.22K 10-Q · filed 2022-08-09 | ||||
| 2021-03-31 | -$45.40K 10-K · filed 2022-06-28 | ||||
| 2014-11-30 | -$71.64K 10-K · filed 2015-03-03 | -$281.30K 10-K · filed 2015-03-03 | |||
| 2013-11-30 | -$54.32K 10-K · filed 2015-03-03 |